Retraction notice to "Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: Molecular characterization of both autoantibodies" [Clin. Immunol. 100 (2001) 219-227];Simultaneous presence of mucous membrane pemphigoid and pemphigus vulgaris: Molecular characterization of both autoantibodies

Clinical Immunology

Volumn 100, Issue 2, 2001, Pages 219-227

  Sami, Naveed ^a   Bhol, Kailash C ^a   Beutner, Ernst H ^b   Plunkett, Richard W ^b   Leiferman, Kristin M ^c   Foster, C Stephen ^d   Ahmed, A Razzaque ^a  

^a NEW ENGLAND BAPTIST HOSPITAL   (United States)

^b Beutner Laboratories   (United States)

^c MAYO CLINIC   (United States)

^d MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Dual diagnosis; IgG subclass; Immunoblot analysis; Indirect immunofluorescence; Pemphigoid; Pemphigus; Salt split skin

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DAPSONE; DESMOGLEIN; IMMUNOGLOBULIN G; METHOTREXATE; PREDNISONE;

ACANTHOLYSIS; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BASEMENT MEMBRANE; BLISTER; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY CELL; KERATINOCYTE; MALE; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; TARGET CELL;

EID: 0034906456     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.03.002     Document Type: Erratum

References (66)

1. Autoantibodies in pemphigus vulgaris
2. The immunopathology of pemphigus and bullous pemphigoid
3. Pemphigus and bullous pemphigoid
4. Pemphigus: Current concepts
5. Pemphigus and pemphigoid
6. Cicatricial pemphigoid
7. A review of mucocutaneous disorders affecting the mouth and lips
8. Differentiating anti-lamina lucida and anti-sub-lamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin
9. The role of human B4 integrin in conjunctival basement membrane separation. Possible in vitro model for OCP
10. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile
11. Use of autoantigen-knockout mice in developing an active autoimmune disease model of pemphigus
12. The anti-desmoglein 1 antibodies in pemphigus vulgaris are pathogenic
13. Anti-intercellular substance antibodies
14. Pemphigus-like antibodies in cicatricial pemphigoid
15. Complement-fixing intercellular antibodies in a case of cicatricial pemphigoid
16. Pemphigus treatment with azathioprine
17. Coexistence of pemphigus vulgaris and ocular cicatricial pemphigoid
18. Intravenous Immunoglobulin therapy for ocular cicatricial pemphigoid. A preliminary study
19. Substrate specificity of anti-epithelial antibodies of pemphigus vulgaris and pemphigus foliaceus sera in immunofluorescence tests on monkey and guinea pig esophagus sections
20. Subclass distribution of human IgG auto-antibodies in pemphigus
21. The subclass distribution of IgG auto-antibodies in cicatricial pemphigoid and EBA
22. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in PV: A model for autoimmunity
23. Bovine gingiva lysate. A novel substrate for rapid diagnosis of mucocutaneous autoimmune vesiculobullous preliminary study
24. Cataract surgery in ocular cicatricial pemphigoid
25. Cicatricial pemphigoid in a patient with systemic lupus erythematosis
26. Cicatricial pemphigoid and rheumatoid arthritis
27. The association between ocular cicatricial pemphigoid and rheumatoid arthritis
28. Cicatricial pemphigoid in a patient with rheumatoid arthritis with penicillamine
29. Cicatricial pemphigoid in D-penicillamine treated patients with arthritis-a report of three cases
30. Association of cicatricial pemphigoid and rheumatoid arthritis
31. Pemphigus vulgaris associated with systemic lupus erythematosis
32. Pemphigus vulgaris associated with systemic lupus erythematosis
33. Systemic lupus erythematosus with pemphigus vulgaris
34. Pemphigus, Sjogren's syndrome and mucosal pigmentation
35. Pemphigus associated with multiple sclerosis
36. Multiple sclerosis and autoimmune skin bullae: A case of pemphigus
37. Juvenile pemphigus vulgaris associated with Grave's disease
38. Myasthenia gravis and pemphigus vulgaris
39. Case of myasthenia gravis associated with pemphigus vulgaris thymectomy. Immunological studies and a review of the literature
40. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis
41. Pemphigus vulgaris and lymphoma in a patient with scleroderma
42. The coexistence of rheumatoid arthritis and systemic lupus erythematosus
43. The coexistence of rheumatoid arthritis and systemic lupus erythematosus
44. Case of coexistence of rheumatoid arthritis and systemic lupus erythematosus
45. The coexistence of rheumatoid arthritis and systemic lupus erythematosus
46. Clinical features of patients with mild systemic erythematosus
47. The coexistence of Sjogren's syndrome and systemic lupus erythematosus
48. Coexistence of serum anti-DNA topisomerase I and anti-Sm antibodies: Report of 3 cases
49. Linear scleroderma occurring in a patient with systemic lupus erythematosus-short report
50. Coexistence of familial systemic erythematosus and local scleroderma
51. Coexistence of lupus erythematosus and scleroderma in light of immunopathological investigations
52. Myasthenia gravis with hyperthyroidism, thymoma and serological evidence of systemic lupus erythematosus: A case report
53. Coexistence of systemic lupus erythematosus and myasthenia gravis
54. Scleroderma with traces of disseminated lupus erythematosus associated with Hashimoto's thyroiditis and papillary carcinoma the thyroid gland
55. The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Clinical and immunogenetic features suggest a distinct entity
56. The coexistence of mutilating rheumatoid arthritis, progressive sclerosis and polycythemia vera-a case report
57. The coexistence of rheumatoid arthritis and scleroderma: A case review of the literature
58. Coexistence of myasthenia gravis and seropositive juvenile chronic arthritis
59. Hashimoto's thyroiditis and polyarthritis: A possible of subset of polyarthritis
60. Unusual autoimmune and neoplastic associated diseases in Sjogren's syndrome
61. Coexistence of multiple sclerosis and myasthenia gravis
62. The association of myasthenia gravis and connective tissue disease the role of Sjogren's syndrome
63. Graves ophthalmopathy and ocular myasthenia
64. The epidemiology of drug treatment failure in rheumatoid arthritis
65. Management of refractory rheumatoid arthritis
66. Therapy of relapsing multiple sclerosis. Treatment for nonresponders